Free tool
Diagnostics stocks
We cover 76 companies grouped under the Diagnostics theme. The median market value in the group is $27.14M. Across the group, the median move over the past trading day is 0.00%. 35% of the 74 with a 200-day average trade above it. Price change over the past year runs from −83.5% to +60.0% across the middle 80 percent of the group, with a median of −15.1%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
76 of 150 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| QGEN | Qiagen N.V. | $43.65 | +6.26% | −3.41% | −10.74% |
| QIA.DE | Qiagen N.V. | 36.41 EUR | −0.78% | −4.56% | −11.42% |
| ALQ.AX | ALS Limited | 22.52 AUD | +3.21% | +2.09% | +23.49% |
| 6869.T | Sysmex Corporation | 1,957.00 JPY | +19.66% | +29.29% | +5.65% |
| SHL.AX | Sonic Healthcare Limited | 20.31 AUD | −7.72% | −7.74% | −11.60% |
| BLLN | BillionToOne, Inc. | $100.08 | −21.80% | +12.08% | −8.14% |
| ADPT | Adaptive Biotechnologies Corporation | $26.25 | +16.46% | +64.99% | +107.18% |
| GRAL | GRAIL, Inc. | $82.54 | +23.62% | −7.12% | +150.69% |
| VCYT | Veracyte, Inc. Common Stock | $44.04 | −20.81% | +3.89% | +49.04% |
| WGS | GeneDx Holdings Corp. | $87.41 | +44.38% | −33.93% | −28.28% |
| NEOG | Neogen Corporation | $11.64 | +24.63% | +66.29% | +107.86% |
| NEO | NeoGenomics, Inc. | $16.79 | +27.78% | +42.77% | +160.31% |
| ALIF-B.ST | AddLife AB (publ) | 162.40 SEK | +0.74% | +8.24% | −7.56% |
| BIOPOR.CO | BioPorto A/S | 1.20 DKK | −0.41% | +15.16% | −6.25% |
| BB1.AX | BLINKLAB FPO [BB1] | 0.86 AUD | +29.55% | +3.64% | +67.65% |
| 7V0.DE | Novogenia AG | 6.10 EUR | −0.81% | −20.26% | −29.07% |
| 6678.T | Techno Medica Co., Ltd. | 2,082.00 JPY | +2.76% | −2.17% | +10.19% |
| AALR3.SA | Alliança Saúde e Participações S.A. | 2.95 BRL | −8.39% | −36.56% | −52.27% |
| SERA | Sera Prognostics, Inc. | $2.18 | +6.34% | −27.33% | −17.42% |
| MDXH | MDxHealth SA | $0.79 | +88.71% | −77.00% | −83.84% |
| LDX.AX | Lumos Diagnostics Holdings Limited | 0.11 AUD | +5.00% | −67.19% | −19.23% |
| KVAC | Keen Vision Acquisition Corp | $12.01 | −6.17% | +2.21% | +4.43% |
| DXR | Daxor Corporation | $10.00 | −2.06% | −30.36% | −7.83% |
| ALKLH.PA | KLEA HOLDING | 0.16 EUR | −1.90% | −30.34% | −29.55% |
| CYC.AX | Cyclopharm Limited | 0.53 AUD | +0.96% | −46.70% | −47.50% |
| BIOBV.HE | Biohit Oyj | 2.56 EUR | −6.57% | −28.89% | −8.24% |
| 0DRP.L | Biohit Oyj | 2.60 EUR | −5.63% | −6.31% | −6.31% |
| ABLD.PA | ABL Diagnostics Société anonyme | 2.36 EUR | −1.67% | −38.54% | −47.32% |
| ALNOV.PA | Novacyt S.A. | 0.51 EUR | +14.60% | +22.38% | +8.44% |
| NCYT.L | Novacyt S.A. | 44.00 GBP | +20.55% | +22.39% | +9.18% |
| PAVM | PAVmed Inc. | $5.28 | +1.44% | −28.04% | −64.04% |
| 2385.T | Soiken Holdings Inc. | 225.00 JPY | +4.17% | −5.06% | +16.58% |
| NXN.AX | Nexsen Ltd | 0.23 AUD | −14.81% | +53.33% | −17.86% |
| COV.AX | Cleo Diagnostics Ltd | 0.34 AUD | +6.25% | −44.72% | −5.56% |
| ACARIX.ST | Acarix AB (publ) | 0.23 SEK | −7.36% | −13.70% | −15.27% |
| MBX.TO | Microbix Biosystems Inc. | 0.30 CAD | −3.23% | +25.00% | +25.00% |
| GDR.L | genedrive plc | 1.38 GBP | +38.00% | +57.71% | +78.06% |
| NN6.DE | NanoRepro AG | 1.85 EUR | −11.48% | +20.13% | −6.09% |
| MAP.AX | Microba Life Sciences Limited | 0.06 AUD | +14.58% | −28.57% | −42.11% |
| ALIKO.PA | Ikonisys S.A. | 1.46 EUR | −2.67% | −9.60% | −3.95% |
| RHY.AX | Rhythm Biosciences Limited | 0.10 AUD | +22.78% | −22.40% | −3.00% |
| 6090.T | Human Metabolome Technologies, Inc. | 637.00 JPY | +7.24% | −4.93% | −14.95% |
| PIQ.AX | Proteomics International Laboratories Ltd | 0.17 AUD | +6.45% | −77.08% | −48.44% |
| ALBIO.PA | Biosynex SA | 0.92 EUR | −0.43% | +58.48% | −22.70% |
| CLBX.L | CelLBxHealth plc | 1.25 GBP | −1.96% | +13.64% | −80.77% |
| 4241.T | atect corporation | 652.00 JPY | +3.49% | +27.44% | +52.40% |
| URT.WA | Urteste S.A. | 43.50 PLN | +0.93% | +2.35% | −14.03% |
| BDX.AX | BCAL Diagnostics Limited | 0.05 AUD | −26.76% | −48.00% | −17.46% |
| IIQ.AX | INOVIQ Ltd | 0.18 AUD | −7.89% | −56.25% | −56.25% |
| GMT.WA | Genomtec S.A. | 3.75 PLN | −6.60% | −0.53% | −38.02% |
| ADVB | Advanced Biomed Inc. | $9.18 | −36.07% | +51.99% | −4.38% |
| BIOVIC-B.ST | Biovica International AB (publ) | 0.44 SEK | −12.60% | +1.39% | −33.59% |
| BACTIQ.CO | BactiQuant A/S | 2.40 DKK | +2.56% | −35.31% | −6.98% |
| TRI.AX | TrivarX Limited | 0.02 AUD | −5.88% | −20.00% | +77.78% |
| BOUL.ST | Boule Diagnostics AB (publ) | 3.21 SEK | −8.29% | −39.20% | −46.85% |
| CRM.WA | PZ Cormay S.A. | 0.52 PLN | +5.48% | +26.83% | +2.77% |
| BMX.WA | BioMaxima S.A. | 10.14 PLN | +1.60% | −17.89% | −22.30% |
| AT1.AX | Atomo Diagnostics Limited | 0.02 AUD | 0.00% | −57.50% | −15.00% |
| GENI.L | GENinCode Plc | 0.88 GBP | +6.06% | −63.54% | −37.50% |
| ACE.ST | Ascelia Pharma AB (publ) | 0.62 SEK | +18.73% | −81.05% | −87.29% |
| CODX | Co-Diagnostics, Inc. | $1.23 | −39.71% | −77.88% | −87.07% |
| ACON | Aclarion, Inc. | $2.49 | +12.16% | −50.00% | −65.89% |
| OBD.L | Oxford BioDynamics Plc | 0.13 GBP | 0.00% | −48.00% | −72.63% |
| INBS | Intelligent Bio Solutions Inc. | $2.36 | +37.21% | −70.09% | −83.95% |
| NDRA | ENDRA Life Sciences Inc. | $4.75 | −0.63% | +10.72% | +6.74% |
| AIDX | 20/20 Biolabs, Inc. | $0.53 | +17.38% | −97.79% | −97.79% |
| IBX.AX | Imagion Biosystems Limited | 0.01 AUD | −16.67% | −61.54% | −37.50% |
| CDIO | Cardio Diagnostics Holdings, Inc. | $1.91 | +17.90% | −32.75% | −45.58% |
| BMRA | Biomerica, Inc. | $1.77 | +9.26% | −30.04% | −48.40% |
| ALPRE.PA | Predilife S.A. | 1.11 EUR | +0.91% | −64.98% | −65.85% |
| BGLC | BioNexus Gene Lab Corp. | $1.55 | +13.14% | −60.66% | −72.52% |
| REVB | Revelation Biosciences, Inc. | $1.00 | −5.66% | −69.25% | −91.21% |
| ONCO | Onconetix, Inc. | $0.64 | −21.01% | −99.20% | −99.57% |
| VRAX | Virax Biolabs Group Limited | $2.91 | −6.13% | +657.81% | +275.97% |
| BJDX | Bluejay Diagnostics, Inc. | $0.92 | −16.71% | −65.03% | −83.87% |
| 0G8X.L | Immunovia AB (publ) | 0.15 SEK | −11.14% | −33.92% | −83.18% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.